Biotech

ANGLE plc: Result of General Meeting

GUILDFORD, ENGLAND: ...

Ceapro Inc. Announces the Launch of its Proprietary Line of Cosmeceutical Products, JUVENTE

EDMONTON, ALBERTA: ...

Novoheart Strengthens North American Presence Opening New R&D Location at the World-class Cove Facility, UC Irvine, California

IRVINE, CALIFORNIA: ...

Prevtec Microbia Receives Market Authorization for Coliprotec(R) F4/F18 in Russia and CIS countries

MONTREAL, QUEBEC: ...

Angle PLC: Researchers Develop Parsortix(TM)-Based Process to Efficiently Harvest Cancer Cells From Bone Marrow

GUILDFORD, SURREY: ...

Critical Outcome Technologies Closes Second Tranche of $2 Million Private Placement

LONDON, ONTARIO and BOSTON, MASSACHUSETTS: Funds to support continued clinical development of COTI-2 in head and neck squamous cell carcinoma ...

Seventh Peer Reviewed Publication on Angle''s Parsortix(TM) System

GUILDFORD, SURREY: ...

Realm Therapeutics Announces Completion of $26 million Private Placement

MALVERN, PA: ...

VBI Vaccines to Present at The World Vaccine Congress Europe 2017 in Barcelona

CAMBRIDGE, MASSACHUSETTS: Presentation to feature overview of positive interim Phase 1 CMV vaccine data and preclinical Zika vaccine data demonstrating neutralizing antibody response ...

Critical Outcome Technologies Announces First Patient Dosed in Phase 1 Trial of COTI-2 in Head and Neck Squamous Cell Carcinoma

LONDON, ONTARIO and BOSTON, MASSACHUSETTS: Top-line Data Expected in 2018 ...